PT726955E - Proteinas quimericas compreendendo polipeptidos borrelia: suas utilizacoes - Google Patents
Proteinas quimericas compreendendo polipeptidos borrelia: suas utilizacoesInfo
- Publication number
- PT726955E PT726955E PT95900453T PT95900453T PT726955E PT 726955 E PT726955 E PT 726955E PT 95900453 T PT95900453 T PT 95900453T PT 95900453 T PT95900453 T PT 95900453T PT 726955 E PT726955 E PT 726955E
- Authority
- PT
- Portugal
- Prior art keywords
- borrelia
- proteins
- polipeptidos
- quimeric
- utilizations
- Prior art date
Links
- 208000016604 Lyme disease Diseases 0.000 title abstract 4
- 241000589968 Borrelia Species 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000037865 fusion proteins Human genes 0.000 abstract 2
- 108020001507 fusion proteins Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14819193A | 1993-11-01 | 1993-11-01 | |
| US08/235,836 US6248562B1 (en) | 1993-11-01 | 1994-04-29 | Chimeric proteins comprising borrelia polypeptides and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT726955E true PT726955E (pt) | 2004-08-31 |
Family
ID=26845620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT95900453T PT726955E (pt) | 1993-11-01 | 1994-10-27 | Proteinas quimericas compreendendo polipeptidos borrelia: suas utilizacoes |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0726955B1 (pt) |
| AT (1) | ATE263836T1 (pt) |
| AU (1) | AU8127494A (pt) |
| CA (1) | CA2175567C (pt) |
| DE (1) | DE69433690T2 (pt) |
| DK (1) | DK0726955T3 (pt) |
| ES (1) | ES2219657T3 (pt) |
| IL (1) | IL111479A0 (pt) |
| PT (1) | PT726955E (pt) |
| WO (1) | WO1995012676A1 (pt) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6676942B1 (en) * | 1991-08-15 | 2004-01-13 | Smithkline Beecham Biologicals (S.A.) | Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines |
| US7008625B2 (en) | 1993-11-01 | 2006-03-07 | Research Foundation Of The State University Of New York | Recombinant constructs of Borrelia burgdorferi |
| CA2193870C (en) * | 1995-12-25 | 2000-07-18 | Nobuyuki Ise | Treponema pallidum fused antigen and assay for anti-treponema pallidum antibodies using the same fused antigen |
| DE19632862B4 (de) | 1996-08-14 | 2006-08-03 | Mikrogen Molekularbiologische Entwicklungs-Gmbh | Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe |
| EP1012269A2 (en) * | 1997-09-10 | 2000-06-28 | Symbicom Ab | P13 antigens from borrelia |
| DE19847142A1 (de) * | 1998-10-13 | 2000-04-27 | Max Planck Gesellschaft | Testkit zur Diagnose von Borreliosen und neue Borrelia-Antigene für die Impfstoffentwicklung |
| US7060281B1 (en) | 1999-06-18 | 2006-06-13 | Research Foundation Of The State University Of New York | Groups of barrelia burgdorferi and borrelia afzelii that cause lyme disease in humans |
| DK1311540T3 (da) | 2000-08-18 | 2008-04-28 | Brookhaven Sciences Ass Llc | Ændret OspA af Borrelia Burgdorferi |
| EP1865062A3 (en) * | 2000-08-18 | 2008-01-09 | Research Foundation Of State University Of New York | Altered OspA of Borrelia burgdorferi |
| AU2001281145A1 (en) * | 2000-08-18 | 2002-03-04 | Brookhaven Sciences Associates, Llc | Recombinant constructs of borrelia burgdorferi |
| EP1939294A1 (en) * | 2000-08-18 | 2008-07-02 | Research Foundation Of State University Of New York | Recombinant constructs of borrelia burgdorferi |
| EP2361930A3 (en) | 2007-03-26 | 2011-10-26 | Dako Denmark A/S | Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases |
| EP2167537A2 (en) | 2007-07-03 | 2010-03-31 | Dako Denmark A/S | Compiled methods for analysing and sorting samples |
| EP2197908A2 (en) | 2007-09-27 | 2010-06-23 | Dako Denmark A/S | Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
| DK2254592T3 (da) | 2008-02-28 | 2019-09-09 | Dako Denmark As | MHC-multimerer til Borrelia-diagnostik og sygdom |
| US10722562B2 (en) | 2008-07-23 | 2020-07-28 | Immudex Aps | Combinatorial analysis and repair |
| GB0817244D0 (en) | 2008-09-20 | 2008-10-29 | Univ Cardiff | Use of a protein kinase inhibitor to detect immune cells, such as T cells |
| US11992518B2 (en) | 2008-10-02 | 2024-05-28 | Agilent Technologies, Inc. | Molecular vaccines for infectious disease |
| WO2010037402A1 (en) | 2008-10-02 | 2010-04-08 | Dako Denmark A/S | Molecular vaccines for infectious disease |
| SI2569008T1 (sl) | 2010-05-14 | 2020-02-28 | Baxalta Incorporated | Himere OSPA in njihova uporaba v cepivih |
| EP3682897A1 (en) | 2012-07-27 | 2020-07-22 | Baxalta GmbH | Compositions comprising chimeric ospa molecules and methods of use thereof |
| CZ2014320A3 (cs) * | 2014-05-09 | 2015-11-18 | VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. | Polyepitopový antigen, vakcinační konstrukt a vakcína pro prevenci lymeské boreliózy |
| EP3213076A1 (en) * | 2014-10-07 | 2017-09-06 | The Research Foundation for The State University of New York | Recombinant borrelia proteins and methods of use thereof |
| EP3898666A2 (en) | 2018-12-17 | 2021-10-27 | Immudex ApS | Panel comprising borrelia mhc multimers |
| US12364744B2 (en) * | 2020-11-25 | 2025-07-22 | Lankenau Institute For Medical Research | Methods and compositions for the diagnosis, prophylaxis and treatment of Lyme disease |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE142888T1 (de) * | 1990-03-05 | 1996-10-15 | Us Health | Antigen-wirkende proteine von borrelia burgdorferi |
| ATE234365T1 (de) * | 1991-10-22 | 2003-03-15 | Symbicom Ab | Verbesserungen der diagnose und der prophylaxe von borrelia burgdorferi |
| WO1994020536A1 (en) * | 1993-03-11 | 1994-09-15 | The Regents Of The University Of California | Methods, compositions, and kits for diagnosing lyme disease |
-
1994
- 1994-10-27 CA CA2175567A patent/CA2175567C/en not_active Expired - Fee Related
- 1994-10-27 AU AU81274/94A patent/AU8127494A/en not_active Abandoned
- 1994-10-27 EP EP95900453A patent/EP0726955B1/en not_active Expired - Lifetime
- 1994-10-27 DE DE69433690T patent/DE69433690T2/de not_active Expired - Lifetime
- 1994-10-27 PT PT95900453T patent/PT726955E/pt unknown
- 1994-10-27 WO PCT/US1994/012352 patent/WO1995012676A1/en not_active Ceased
- 1994-10-27 AT AT95900453T patent/ATE263836T1/de active
- 1994-10-27 DK DK95900453T patent/DK0726955T3/da active
- 1994-10-27 ES ES95900453T patent/ES2219657T3/es not_active Expired - Lifetime
- 1994-10-31 IL IL11147994A patent/IL111479A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU8127494A (en) | 1995-05-23 |
| DK0726955T3 (da) | 2004-08-09 |
| WO1995012676A1 (en) | 1995-05-11 |
| CA2175567A1 (en) | 1995-05-11 |
| ES2219657T3 (es) | 2004-12-01 |
| ATE263836T1 (de) | 2004-04-15 |
| EP0726955A1 (en) | 1996-08-21 |
| DE69433690D1 (de) | 2004-05-13 |
| DE69433690T2 (de) | 2005-03-10 |
| EP0726955B1 (en) | 2004-04-07 |
| IL111479A0 (en) | 1994-12-29 |
| CA2175567C (en) | 2010-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT726955E (pt) | Proteinas quimericas compreendendo polipeptidos borrelia: suas utilizacoes | |
| WO1996034107A3 (en) | Antiviral proteins, dna coding sequences therefor, and uses thereof | |
| PT100781A (pt) | Sequencias de dna codificadoras de proteinas de superficie externa, proteinas contendo as referidas sequencias, obtidas a partir de borrelia burgdorferi, e vacinas contendo as referidas proteinas | |
| DK0765394T3 (da) | Oprensede Myceliopthora-laccaser og nukleinsyrer der koder for disse | |
| DE60140474D1 (de) | Sammlung von proteinen mit sich wiederholenden sequenzen (repeat proteins), die repetitive sequenzmodule enthalten | |
| ATE215601T1 (de) | Rezeptoren der steroid/thyroid superfamilie von rezeptoren | |
| ATE310090T1 (de) | Gereinigte coprinus laccasen und nukleinsäuren welche dafür kodieren | |
| FI821466A7 (fi) | Bacillus-kloonausvektorit, yhdistelmä- DNA-molekyylit, niiden transformoimat Bacillus-isännät sekä menetelmätvieraiden DNA- sekvenssien ekspressiota varten sekä näiden koodaamien polypeptidien tuottamiseksi. | |
| DE69434166D1 (de) | Menschliche metabotropische glutamatrezeptor untertype hmglur7 und verwandte dns-verbindungen | |
| DK1482040T3 (da) | NL3-TIE-receptortyrosinkinaseligandhomologer | |
| CH0229046H1 (de) | Method for obtaining dna, rna, peptides, polypeptinique. des or proteins by means of a dna recombinant tech | |
| DK1311682T3 (da) | Rekombinante konstruktioner af Borrelia burgdorferi | |
| DK1131444T3 (da) | Polypeptider med lysophospholipase aktivitet og nucleinsyre som koder for disse | |
| DK296189D0 (da) | Nucleinsyresekvenser, som koder for peptidsekvenser af carcinoembryonisk antigen-familien | |
| PL351277A1 (en) | Nucleic acid sequence, dna fragments, recombined dna molecules, live recombined carriers, host cells, proteins and their application, vaccines against lawsonia intracellularis and methods of obtaining them as well as relevant diagnostic tests | |
| DK0870046T3 (da) | Levende rekombinant vaccine som indeholder felint herpesvirus type 1, især til behandling af felin infektiös peritonitis | |
| FI951680L (fi) | DNA-yhdisteitä, jotka sisältävät mannuronaani-C-5-epimeraasia koodaavia sekvenssejä | |
| WO2001021807A8 (en) | Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof | |
| DK0393502T3 (da) | Opløselige interferon-gamma-receptorer og fremgangsmåder til fremstilling heraf | |
| DK0643719T3 (da) | Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor | |
| DK57487A (da) | Humant lymphotoxinpolypeptidderivat og fremgangsmaade til fremstilling deraf, dna-fragment, som koder for derivatet, rekombinante plasmider, som har inkorporeret fragmentet, og biologisk rene kulturer af mikroorganismer indeholdende saadanne plasmider | |
| ATE367827T1 (de) | Verfahren zur reduzierung der immunogenizität der variablen regionen von antikörpern | |
| DK0672124T3 (da) | Anvendelse af en DNA-sekvens, der koder for et oxalsyre-nedbrydende protein i form af et selektionsgen | |
| DE58908276D1 (de) | Verfahren zur Oligomerisation von Hexafluorpropenoxid. | |
| DK1078072T3 (da) | Nye peptidfragmenter til oprensning af proteiner |